PenderFund Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-30,100
Closed -$211K 152
2024
Q3
$211K Buy
+30,100
New +$211K 0.05% 101